Chapter 4.2 Flashcards
Thrombin
Most important coagulation factor
Converts plasma protein fibrinogen into fibrin monomers that polymerize into an insoluble gel
Gel encases platelets and other circulating cells in Secondary Hemostatic plut
Cross linked and stabilized by factor XIIIa
PT Assay
Function of factors 7, 10, 2 and 5 and fibrinogen
Add tissue factor and phospholipids to citrated plasma (prevents spontaneous clotting)
Initiated by exogenous Ca2+ and the time for fibrin clot formation is recorded
PTT
Screens 12, 11, 9, 8, 10, 5, II and fibrinogen
Clotting initiated through the addition of negatively charged particles
Activates factor 12 Hageman factor, phospholipids and Ca2+, time to fibrin clot formation is recorded
PARs
Protease Activated Receptors
7 Transmembrane G protein coupled receptor family
Expressed on endothelium, monocytes, dendritic cells, T-lymphocytes, etc
Antithrombin III
Inhibits activity of thrombin and other serine proteases, IXa, Xa, XIa and XIIa
Activated by binding to heparin-like molecules on endothelial cells
Administer heparin to minimize thrombosis
Protein C and S
Vitamin K-dependent proteins
Act in complex that proteolytically inactivates Va and VIIIa
TFPI:
protein produced by endothelium
Inactivates tissue factor-factor VIIa complexes
PAI
Plasminogen activator inhibitor PAI
Blocks fibrinolysis by inhibiting t-PA binding to fibrin
Confers an overall procoagulant effect
Production is increased by thrombin as well as other cytokines
Virchows Triad
- Endothelial injury
- Stasis or turbulent blood flow
- Hypercoagulability of blood
Endothelial injury
Any perturbation in the dynamic balance of prothombic and antithrombotic activities of endothelium can influence local clotting events
Turbulance
Contributes to arterial and cardiac thrombosis by causing endothelial injury or dysfunction
Countercurrents and local pockets of stasis
Stasis contributes to development of venous thrombi
Enhance pro-coagulant activity
Hypercoagulability
Less frequent contributor to thrombotic states
Alteration of coagulation pathways, predispose to thrombosis
Inherited Hypercoagulability
Most common
Pt mutations in factor V gene
Prothrombin gene
Elevated Homocysteine
Contirubtes to arterial and venous thrombosis
Thioester linkages occur between homocysteine metabolites and a variety of proteins
Causes of Venous Thrombosis or Recurrent Thromboembolism
Deficiencies of anticoagulants
Antithrombin III, protein C or protein S
Heparin-induced thrombocytopenia
Occurs after administratoin of unfractionated heparin
Can induce appearence of ABs
Recognize complexes of heparain and platelet factor 4 on platelet surface
Will see low platelet counts
Anti-phospholipid syndrome
Recurrent thromboses, repeated miscarriages, cardiac valve vegetations, thrombocytopenia
Pulmonary embolism, pulmonary hypertension, stroke, bowel infarction, renovascular hypertension
Autoantibodies can induce hypercoagulable state
Cause endothelial injury
Secondary Anti-Phospholipid Syndrome
Individuals with well defined autoimmune disease
Systemic lupus erythematosus
Primary Anti-Phospholipid Syndrome
Only manifestations of hypercoagulable state
Lack evidence of other autoimmune disorders
Associate with certain drugs or infections
Arterial thrombi
Grow retrograde from pt of attachment
Begin at sites of turbulence or endothelial injury
Occlusive
Common in coronary, cerebral, femoral arteries
Meshwork of platelets, fibrin, red cells, degenerating leukocytes
Superimposed on ruptures atherosclerotic plaque
Venous Thrombi
extend in direction of blood flow Occur at sites of stasis Invariably occlusive Long cast of lument Sluggish venous circulation More enmeshed red cells 90% cases veins in LE
Lines of Zahn
Alternating lines of platelet and fibrin deposits
Indicate that a thrombus has formed in flowing blood
Can be distinguished from antemortem thrombosis from bland nonlaminated clots
Postmortem thrombus
Dark red dependent protion
RBCs settled by gravity
Yellow chicken fat upper protion
Not underlying wall